** = Publikationen gelistet in SCI/SSCI/Pubmed
** Mooslechner, AA; Schuller, M; Artinger, K; Kirsch, AH; Schabhüttl, C; Eller, P; Rosenkranz, AR; Eller, K
Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8+ T Cells.
Cells. 2022; 11(22):
Doi: 10.3390/cells11223656
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schuller, M; Pfeifer, V; Kirsch, AH; Klötzer, KA; Mooslechner, AA; Rosenkranz, AR; Stiegler, P; Schemmer, P; Sourij, H; Eller, P; Prietl, B; Eller, K
B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response.
Front Med (Lausanne). 2022; 9: 818882
Doi: 10.3389/fmed.2022.818882
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aringer, I; Artinger, K; Schabhüttl, C; Bärnthaler, T; Mooslechner, AA; Kirsch, A; Pollheimer, M; Eller, P; Rosenkranz, AR; Heinemann, A; Eller, K
Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice.
J Clin Med. 2021; 10(4):
Doi: 10.3390/jcm10040832
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Artinger, K; Kirsch, AH; Mooslechner, AA; Cooper, DJ; Aringer, I; Schuller, M; Schabhüttl, C; Klötzer, KA; Schweighofer, K; Eller, P; Yagita, H; Illert, AL; Rosenkranz, AR; Lane, PJ; Eller, K, ;RITERM, study, group
Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
Kidney Int. 2021; 100(2):336-348
Doi: 10.1016/j.kint.2021.02.039
Web of Science
PubMed
FullText
FullText_MUG
** Mooslechner, AA; Schuller, M; Artinger, K; Kirsch, AH; Schabhuttl, C; Rosenkranz, AR; Eller, K
Regulatory potential of local Ly49(+)CD8(+) memory T cell abundance in chronic kidney disease
EUR J IMMUNOL. 2021; 51: 247-247.
Web of Science
** Moschovaki Filippidou, F; Kirsch, AH; Thelen, M; Kétszeri, M; Artinger, K; Aringer, I; Schabhüttl, C; Mooslechner, AA; Frauscher, B; Pollheimer, M; Niedrist, T; Meinitzer, A; Drucker, DJ; Pieber, TR; Eller, P; Rosenkranz, AR; Heinemann, A; Eller, K
Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.
Am J Pathol. 2020; 190(2):400-411
Doi: 10.1016/j.ajpath.2019.10.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kétszeri, M; Kirsch, A; Frauscher, B; Moschovaki-Filippidou, F; Mooslechner, AA; Kirsch, AH; Schabhuettl, C; Aringer, I; Artinger, K; Pregartner, G; Ekart, R; Breznik, S; Hojs, R; Goessler, W; Schilcher, I; Müller, H; Obermayer-Pietsch, B; Frank, S; Rosenkranz, AR; Eller, P; Eller, K
MicroRNA-142-3p improves vascular relaxation in uremia.
Atherosclerosis. 2019; 280(1):28-36
Doi: 10.1016/j.atherosclerosis.2018.11.024
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aringer, I; Artinger, K; Kirsch, AH; Schabhüttl, C; Jandl, K; Bärnthaler, T; Mooslechner, AA; Herzog, SA; Uhlig, M; Kirsch, A; Frank, S; Banas, M; Pollheimer, M; Eller, P; Rosenkranz, AR; Heinemann, A; Eller, K
Blockade of prostaglandin E2 receptor 4 ameliorates nephrotoxic serum nephritis.
Am J Physiol Renal Physiol. 2018; 315(6):F1869-F1880
Doi: 10.1152/ajprenal.00113.2018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mooslechner, A; Kirsch, A; Artinger, K; Aringer, I; Moschovaki-Filippidou, F; Schabhuttl, C; Rosenkranz, A; Eller, K
THE ROLE OF CD8(+) T LYMPHOCYTES IN EXPERIMENTAL NEPHROTOXIC SERUM NEPHRITIS
NEPHROL DIAL TRANSPL. . 2018; 33: 409-409.-55th ERA-EDTA Congress; MAY 24-27, 2018; Copenhagen, DENMARK.
[Poster]
Web of Science
** Guenther, S; Loebel, M; Mooslechner, AA; Knops, M; Hanitsch, LG; Grabowski, P; Wittke, K; Meisel, C; Unterwalder, N; Volk, HD; Scheibenbogen, C
Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.
Hum Immunol. 2015; 76(10): 729-735.
Doi: 10.1016/j.humimm.2015.09.028
Web of Science
PubMed
FullText
FullText_MUG
** Löbel, M; Mooslechner, AA; Bauer, S; Günther, S; Letsch, A; Hanitsch, LG; Grabowski, P; Meisel, C; Volk, HD; Scheibenbogen, C
Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.
J Transl Med. 2015; 13(10): 264-264.
Doi: 10.1186/s12967-015-0628-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG